期刊文献+

血友病甲患者血浆中修饰型组织因子途径抑制物的研究 被引量:3

The Study on Trunpucated TFPI Level in Plasma of Hemophilia A
下载PDF
导出
摘要 目的:探测血友病甲患者血浆修饰型组织因子途径抑制物(TFPI)水平的变化及其与活化部份凝血酶时间(APTT)时间的相关性。方法:以ELISA法测定修饰型TFPI含量,以凝血一期法在半自动凝血仪上测定APTT与FⅧ:C。结果:28例血友病患者血浆修饰型TFPI含量与正常组相比差异无显著性,与APTT呈正相关,与FⅧ:C不相关。结论:血友病甲患者修饰型TFPI含量与正常无差异,完全可能通过低调TFPI水平而达到止血冶疗的目的。 Objective: To explore and dectect the changes of the trunqucated tissue factor pathway in-hibitor(TFPI) level in plasma of hemophilia A and it's correlation between the activated partial thrombo-plastin time(APTT) and FⅧ:C. Methods: The volumn of the trunpucated TFPI is measured by means of ELISA method, the APTT and FⅧI:C is detected by the first cloting stage method. Results: There is no significant difference of the plasma TFPI volumn between 28 case hemophitia A and normal control group. The plasma TFPI volumn is positive correlation with the APTT. But no correlation with the FⅧ:C. Conclusion: The trunpucated TFPI volumn in plasma of hemophihia A is no significant differents to the normal, it is possible to low regulate the TFPI level so to regain the hemostasis theraputic purpose.
出处 《血栓与止血学》 2002年第4期160-161,共2页 Chinese Journal of Thrombosis and Hemostasis
关键词 血友病甲 组织因子途径抑制物 凝血因子Ⅷ活性 血浆修饰型 ELISA法 Hemophilia A Tissue factor pathway inhibitor FⅧ:C
  • 相关文献

参考文献1

  • 1-.首届中华血液学会全国血栓与止血学会议有关凝血疾病的诊断标准(修订案)[J].中华血液学杂志,1987,8:183-183.

同被引文献22

  • 1吴晓燕,任江华,曹茂银.维生素E对组织因子及其抑制物在冠心病中的干预作用[J].临床心血管病杂志,2004,20(10):616-618. 被引量:6
  • 2The extrinsic pathway inhibitor:A regulator of tissue factor-dependent blood coagulation[J].Thromb Haemost,1991,66:6-15.
  • 3ERHARDTSEN E,EZBAN M,MADSEN MT,et al.Blocking of tissue factor pathway inhibitor (TFPI)shortens the bleeding time in rabbits with antibody induced haemophilia A[J].Blood Coagul Fibrinolysis,1995,6(5):388-394.
  • 4LIU T,SCALLAN CD,BROZE GJ JR,et al.Improved coagulation in bleeding disorders by non-anticoagulant sulfated polysaccharides (NASP)[J].Thromb Haemost,2006,95(1):68-76.
  • 5PRASAD S,LILLICRAP D,LABELLE A,et al.Efficacy and safety of a new-class of hemostatic drug candidate,AV513,in hemophilia A dogs[J].Blood,2008,111:672-679.
  • 6SHETTY S,VORA S,KULKARNI B,et,al.Contribution of natural anticoagulant and frbrinolytic factors in modulating the clinical severity of haemophilia patients[J].British Journal of Haemotology,2007,138:541-544.
  • 7KUBISZ P,STASKO D J,DOBROTOVA M,et,al.Severe hemophilia and physiologic inhibitors of coagulation[J].Clin Appl Thrombosis/Hemostasis,2005,11:331-334.
  • 8BRINKMANN T,KANHERT H,PROHASKA W,et al.Synthesis of tissue factor inhibitor in human synovial cells and chondrocytes makes joints predilected site of bleeding in haemophiliacs[J J.Eur J Chin Chem Clin Biochem,1994,32(4):313-317.
  • 9阮长耿.血栓与止血-现代理论与临床实践[M]南京:江苏科学技术出版社,1994(5):119-128.
  • 10Ghosh K,Shetty S,Mohanty D. Milder clinical presentation of haemophilia A with severe deficiency of factor Ⅷ as measured by one-stage assay[J].Haemophilia,2001,(01):9-12.

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部